[Use of methamidoline in the treatment of parkinson-like manifestations due to neuroleptics].
D000328:Adult; D000368:Aged; D000814:Aniline Compounds / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010880:Piperidines / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000009:adverse effects*
D000814:Aniline Compounds; D000978:Antiparkinson Agents; D007211:Indoles; D010880:Piperidines; D014149:Tranquilizing Agents
Sull'impiego della metamidolina nel trattamento delle manifestazioni parkinsonismili da neurolettici.